New PDUFA action date announced by the US FDA for Injectafer® New Drug Application
Galenica's U.S. partner, Luitpold Pharmaceuticals, Inc., has received confirmation from the US Food and Drug Administrat…
Galenica's U.S. partner, Luitpold Pharmaceuticals, Inc., has received confirmation from the US Food and Drug Administrat…
The Galenica Group recorded profit growth for the 17th consecutive year in 2012: consolidated net profit rose 13.6% to C…
Die Ergebnisse einer neuen klinischen Studie zeigen, dass eine Einzeldosis von 1'000 mg des intravenös zu verabreichende…